Back to News
Market Impact: 0.6

Super Micro Computer: Guidance Implies A Major Growth Inflection In 2H FY2026 (Rating Upgrade)

SMCINVDA
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst InsightsInvestor Sentiment & PositioningArtificial IntelligenceTechnology & Innovation
Super Micro Computer: Guidance Implies A Major Growth Inflection In 2H FY2026 (Rating Upgrade)

Super Micro Computer (SMCI) shares experienced a 20% pullback after the company missed 4Q FY2025 revenue and EPS estimates and issued weak 1Q FY2026 guidance, alongside a reduced FY2026 revenue outlook from $40 billion to "at least" $33 billion. Despite these near-term headwinds, management projects a significant growth inflection in 2H FY2026, driven by large shipments of NVIDIA's GB200 and DCBBS systems, which are anticipated to comprise 30% of total revenue by summer 2026. While margins are expected to recover only gradually and remain pressured, this implied acceleration in high-value AI infrastructure sales is seen as justifying the stock's current 17.5x forward non-GAAP P/E amidst broader sector rerating.

Analysis

Super Micro Computer (SMCI) is navigating a period of significant near-term headwinds, evidenced by its 4Q FY2025 revenue and EPS miss, which precipitated a 20% stock pullback. This was compounded by weak 1Q FY2026 guidance and a material reduction in the full-year FY2026 revenue outlook from $40 billion to "at least" $33 billion. However, the core investment thesis now pivots to a major growth inflection anticipated in the second half of fiscal 2026. This expected acceleration is predicated on large-scale shipments of high-value systems, specifically those incorporating NVIDIA’s Blackwell GB200 architecture and the company's own DCBBS solutions, which are forecast to constitute 30% of total revenue by the summer of 2026. While gross margins are expected to recover only gradually due to competitive pressures and are unlikely to revisit the prior 15% peak soon, the stock's forward non-GAAP P/E of 17.5x is framed as justifiable. This valuation is supported by a broader semiconductor sector rerating and investor optimism for the company's pronounced, albeit delayed, growth recovery.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo